Static data

Name
Candriam Eq. L Biotechnology N $
Sicav
Candriam Equities L Sicav
Assogestioni category
Health-Care Equity
Official Benchmark
Nasdaq Biotechnology Net TR Index (100.00%)
SRRI (risk value)
5
Start date
8/22/2002
Currency
United States Dollar
NAV Currency
United States Dollar
Status
Active
Income distribution
Accumulation

FIDArating

Date
-
Rating
-
Score
-
Category
Equity Sector - Biotechnology

Issuing company

Name
Candriam
Address
Serenity Bloc B 19-21, route d'Arlon - L-8009 Strassen
Web
www.candriam.com

Fida factsheet

Factsheet of all key data and Key performance of ETF/fund (by FIDA)

Download

Last update 1/31/2026.


Policy

-


Investments and fees

Management Fee
2.00%

Subscription fee
0.00%
Performance Fee
0.00%
Redemption fee
0.00%
Switch Fee
0.00%

Single payment solution

Initial payment
-
Subsequent payment
-
Transaction currency
Euro


FondiDoc SmartHelpDesk